Which one of the following strategies is NOT used in the treatment of Parkinson’s disease?Group of answer choicesAgents that act as dopamine receptor agonists in the brain.Agents that diminish the actions of acetylcholine in the brain.Agents that inhibit dopa decarboxylase in the brain.Agents that decrease the breakdown of dopamine.
Question
Which one of the following strategies is NOT used in the treatment of Parkinson’s disease?Group of answer choicesAgents that act as dopamine receptor agonists in the brain.Agents that diminish the actions of acetylcholine in the brain.Agents that inhibit dopa decarboxylase in the brain.Agents that decrease the breakdown of dopamine.
Solution 1
The strategy that is NOT used in the treatment of Parkinson’s disease is "Agents that diminish the actions of acetylcholine in the brain."
Parkinson's disease is primarily associated with a deficiency of dopamine in the brain. Therefore, treatments typically aim to increase dopamine levels or activity in the brain. This can be achieved through the use of dopamine receptor agonists, which mimic the action of dopamine, or agents that inhibit dopa decarboxylase, which is an enzyme involved in the breakdown of dopamine. Agents that decrease the breakdown of dopamine are also used to prolong the action of dopamine in the brain.
On the other hand, acetylcholine is another neurotransmitter that is typically in balance with dopamine. In Parkinson's disease, due to the decrease in dopamine, there may be relative overactivity of acetylcholine. However, diminishing the actions of acetylcholine is not a primary strategy in the treatment of Parkinson's disease. While some medications may have anticholinergic effects, these are typically used to manage symptoms (like tremors) and not as a primary treatment strategy.
Solution 2
The strategy that is NOT used in the treatment of Parkinson’s disease is "Agents that diminish the actions of acetylcholine in the brain."
Here's why:
-
Agents that act as dopamine receptor agonists in the brain: These are used in the treatment of Parkinson's disease. They work by mimicking the effects of dopamine in the brain, which can help to reduce symptoms.
-
Agents that diminish the actions of acetylcholine in the brain: These are NOT typically used in the treatment of Parkinson's disease. Parkinson's disease is primarily associated with a decrease in dopamine, not an overactivity of acetylcholine.
-
Agents that inhibit dopa decarboxylase in the brain: These are used in the treatment of Parkinson's disease. By inhibiting this enzyme, more levodopa is available to be converted into dopamine in the brain, which can help to reduce symptoms.
-
Agents that decrease the breakdown of dopamine: These are used in the treatment of Parkinson's disease. By preventing the breakdown of dopamine, these drugs can help to increase the amount of dopamine in the brain, which can help to reduce symptoms.
Similar Questions
Alzheimer’s disease is commonly treated with a centrally acting:Group of answer choicesdopamine receptor antagonist.acetylcholinesterase inhibitor.choline acetyltransferase inhibitor.acetylcholine receptor antagonist.
One reason that the Nurr1 nuclear receptor is an attractive target for Parkinson disease drugs is it's specific expression in dopaminergic neurons of the substantia nigra.Group of answer choicesTrueFalse
Parkinson’s disease is a chronic progressive neurodegenerative disorder resulting in the loss of dopamine-producing cells in which brain structure? Group of answer choicesSubstantia nigraCingulate gyrusHippocampusHypothalamus
Which of the following agents can be used to counter the effects of acetylcholine?Group of answer choicesSuxamethoniumAtropineNeostigmineAtenolol
Neuroleptic drugs are known to affect what neurotransmitter?Multiple choice question.SerotoninDopamineNorepinephrineAcetylcholine
Upgrade your grade with Knowee
Get personalized homework help. Review tough concepts in more detail, or go deeper into your topic by exploring other relevant questions.